Open Label Extension for 43USSA1812
Public ClinicalTrials.gov record NCT04595331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open Label Extension for 43USSA1812 (A Randomized, Evaluator-blinded, No-treatment Controlled, Multi-center Study to Evaluate the Effectiveness and Safety of Sculptra Aesthetic for Correction of Cheek Wrinkles)
Study identification
- NCT ID
- NCT04595331
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Galderma R&D
- Industry
- Enrollment
- 111 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 11, 2019
- Primary completion
- Jul 19, 2022
- Completion
- Jul 19, 2022
- Last update posted
- Jun 25, 2025
2019 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Research Site | Scottsdale | Arizona | 85255 | — |
| Galderma Research Site | Encino | California | 91436 | — |
| Galderma Research Site | Redondo Beach | California | 90277 | — |
| Galderma Research site | San Diego | California | 92121 | — |
| Galderma Research Site | Washington D.C. | District of Columbia | 20037 | — |
| Galderma Research Site | Coral Gables | Florida | 33143 | — |
| Galderma Research Site | Alpharetta | Georgia | 30022 | — |
| Galderma Research Site | New Orleans | Louisiana | 70115 | — |
| Galderma Research Site | Rockville | Maryland | 20852 | — |
| Galderma Research Site | New York | New York | 10021 | — |
| Galderma Research Site | New York | New York | 10028 | — |
| Galderma Research Site | Dallas | Texas | 75254 | — |
| Galderma Research Site | Spring | Texas | 77388 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04595331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04595331 live on ClinicalTrials.gov.